Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ChromaDex Q1 2024 Adj EPS $(0.01) Beats $(0.02) Estimate, Sales $22.200M Miss $23.970M Estimate

Author: Benzinga Newsdesk | May 08, 2024 04:05pm
ChromaDex (NASDAQ:CDXC) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. The company reported quarterly sales of $22.200 million which missed the analyst consensus estimate of $23.970 million by 7.38 percent. This is a 1.58 percent decrease over sales of $22.556 million the same period last year.

Posted In: CDXC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist